3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
11
Multiple Myeloma
9
Recurrence
7
Lymphoma, B-Cell
7
Hematologic Neoplasms
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma
6
Hodgkin Disease
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Colorectal Neoplasms
5
Burkitt Lymphoma
5
Stomach Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Sarcoma
3
Osteosarcoma
3
Myeloproliferative Disorders
3
Leukemia, B-Cell
3
Leukemia
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Interventions
atezolizumab
2
cabozantinib
1
Specimen Handling
1
Immunoglobulin G
1
Disulfides
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
fludarabine
×
30 days
×
Clear all
No trials found.